Average Co-Inventor Count = 3.83
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Syntex (u.s.a.) Inc. (23 from 932 patents)
2. Celgene Avilomics Research, Inc. (20 from 44 patents)
3. Kymera Therapeutics, Inc. (13 from 32 patents)
4. Mitobridge, Inc. (12 from 20 patents)
5. Celgene Car LLC (8 from 44 patents)
6. The Salk Institute for Biological Studies (7 from 574 patents)
7. Avila Therapeutics, Inc. (4 from 5 patents)
8. Agennix USA Inc. (3 from 3 patents)
9. Other (2 from 831,952 patents)
10. Forma Therapeutics, Inc. (2 from 124 patents)
11. Gpc Biotech, Inc. (2 from 13 patents)
12. Cubist Pharmaceuticals, Incorporated (1 from 59 patents)
13. Forma Tm, LLC (1 from 10 patents)
14. Gpc Biotech Ag (1 from 6 patents)
15. Innate Biotherapeutics, LLC (1 from 2 patents)
93 patents:
1. 12258341 - IRAK degraders and uses thereof
2. 12168057 - IRAK degraders and uses thereof
3. 12006329 - Protein degraders and uses thereof
4. 11993585 - Poly-ADP ribose polymerase (PARP) inhibitors
5. 11932635 - CRBN ligands and uses thereof
6. 11897882 - Tricyclic crbn ligands and uses thereof
7. 11807636 - IRAK degraders and uses thereof
8. 11723980 - IRAK degraders and uses thereof
9. 11578052 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
10. 11512080 - CRBN ligands and uses thereof
11. 11485743 - Protein degraders and uses thereof
12. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
13. 11352350 - IRAK degraders and uses thereof
14. 11292792 - Tricyclic CRBN ligands and uses thereof
15. 11117889 - IRAK degraders and uses thereof